WASHINGTON — Justice Department antitrust enforcers are preparing to give the green light to two deals in the health-care industry, CVS Health Corp.’s CVS, +1.20% planned acquisition of health insurer Aetna Inc. AET, +1.32% and Cigna Corp.’s CI, -0.61% planned purchase of Express Scripts Holding Co. ESRX, +3.31% , according to people familiar with the matter.
Both deals could receive formal antitrust approval as soon as the next few weeks, these people said.
The Justice Department has identified some competition concerns surrounding the nearly $70 billion CVS-Aetna deal, and the companies will be required to sell off assets related to Medicare drug coverage to resolve those issues, some of the people familiar with the matter said.
The department’s approval of the $54 billion Cigna and Express Scripts combination could come without the government requiring the companies to sell off any assets, said some of the people who were familiar with the review of that deal.
An expanded version of this report appears on WSJ.com.
Also popular on WSJ.com:
Nike risks backlash with Colin Kaepernick deal.
Blood-testing firm Theranos to dissolve.